Your browser doesn't support javascript.
Obesity and its implications on cerebral circulation and intracranial compliance in severe COVID-19.
Brasil, Sérgio; Renck, Alessandra Covallero; Taccone, Fabio Silvio; Fontoura Solla, Davi Jorge; Tomazini, Bruno Martins; Wayhs, Sâmia Yasin; Fonseca, Sérgio; Bassi, Estevão; Lucena, Bruno; De Carvalho Nogueira, Ricardo; Paiva, Wellingson; Teixeira, Manoel Jacobsen; Frade Costa, Elaine Maria; Sá Malbouisson, Luiz Marcelo.
  • Brasil S; Universidade de São Paulo Brazil.
  • Renck AC; Universidade de São Paulo Brazil.
  • Taccone FS; Universitè Libre de Bruxelles Belgium.
  • Fontoura Solla DJ; Universidade de São Paulo Brazil.
  • Tomazini BM; Universidade de São Paulo Brazil.
  • Wayhs SY; Universidade de São Paulo Brazil.
  • Fonseca S; Universidade de São Paulo Brazil.
  • Bassi E; Universidade de São Paulo Brazil.
  • Lucena B; Universidade de São Paulo Brazil.
  • De Carvalho Nogueira R; Universidade de São Paulo Brazil.
  • Paiva W; Universidade de São Paulo Brazil.
  • Teixeira MJ; Universidade de São Paulo Brazil.
  • Frade Costa EM; Universidade de São Paulo Brazil.
  • Sá Malbouisson LM; Universidade de São Paulo Brazil.
Obes Sci Pract ; 7(6): 751-759, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1242755
ABSTRACT

Objective:

Multiple factors have been identified as causes of intracranial compliance impairment (ICCI) among patients with obesity. On the other hand, obesity has been linked with worst outcomes in COVID-19. Thus, the hypothesis of severe acute respiratory syndrome (SARS) conducing to cerebral hemodynamic disorders (CHD) able to worsen ICCI and play an additional role on prognosis determination for COVID-19 among obese patients becomes suitable.

Methods:

50 cases of SARS by COVID-19 were evaluated, for the presence of ICCI and cerebrovascular circulatory disturbances in correspondence with whether unfavorable outcomes (death or impossibility for mechanical ventilation weaning [MVW]) within 7 days after evaluation. The objective was to observe whether obese patients (BMI ≥ 30) disclosed worse outcomes and tests results compared with lean subjects with same clinical background.

Results:

23 (46%) patients among 50 had obesity. ICCI was verified in 18 (78%) obese, whereas in 13 (48%) of 27 non-obese (p = 0,029). CHD were not significantly different between groups, despite being high prevalent in both. 69% unfavorable outcomes were observed among obese and 44% for lean subjects (p = 0,075).

Conclusion:

In the present study, intracranial compliance impairment was significantly more observed among obese subjects and may have contributed for SARS COVID-19 worsen prognosis.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Obes Sci Pract Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Obes Sci Pract Year: 2021 Document Type: Article